BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 461.70M
Enterprise value 416.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)114.47
Price/book (mrq)1.30
Enterprise value/revenue 103.35
Enterprise value/EBITDA -1.73

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 311.45%
S&P500 52-week change 32.54%
52-week high 38.5800
52-week low 32.7800
50-day moving average 33.7846
200-day moving average 35.8353

Share statistics

Avg vol (3-month) 34.76M
Avg vol (10-day) 33.68M
Shares outstanding 5106.41M
Implied shares outstanding 6N/A
Float 889.86M
% held by insiders 11.04%
% held by institutions 170.26%
Shares short (14 May 2023) 423.49M
Short ratio (14 May 2023) 45.32
Short % of float (14 May 2023) 424.94%
Short % of shares outstanding (14 May 2023) 422.07%
Shares short (prior month 13 Apr 2023) 423.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21544:1000
Last split date 304 Nov 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-3,802.85%

Management effectiveness

Return on assets (ttm)-16.19%
Return on equity (ttm)-39.87%

Income statement

Revenue (ttm)4.03M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)22.40%
Gross profit (ttm)-247.24M
EBITDA -148.3M
Net income avi to common (ttm)-123.19M
Diluted EPS (ttm)-1.4500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)318.26M
Total cash per share (mrq)2.99
Total debt (mrq)273.38M
Total debt/equity (mrq)77.06
Current ratio (mrq)3.03
Book value per share (mrq)3.34

Cash flow statement

Operating cash flow (ttm)-314.3M
Levered free cash flow (ttm)-118.39M